An official website of the United States government
Home
Name
Cetuximab
Alternate Names
C 225
C-225
C225
Erbitux
IMC-C225
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
NSC Number
714692
Primary Site
Histology
None
Remarks
JANUARY 2013 IMPORTANT UPDATE: This drug has changed categories. A comprehensive review has been completed and in keeping with the FDA, cetuximab is to be coded as a Biologic therapy/Immunotherapy agent. Effective with diagnosis date January 1, 2013 forward, code cetuximab as BRM/Immunotherapy. For cases diagnosed prior to January 1, 2013 continue coding this drug as chemotherapy.
FDA approved colorectal 2004, head and neck 2006; orphan drug for pancreas
Anti-VEGFr chimeric monoclonal antibody.
FDA approved colorectal 2004, head and neck 2006; orphan drug for pancreas
Anti-VEGFr chimeric monoclonal antibody.
Coding
This drug should be coded
